TMCnet News
Rex - The Talking Prescription Bottle Up for Speech Solution Award PITTSBURGH --(Business Wire)-- Aug. 18, 2004 -- Wizzard Software Corp. (OTCBB:WIZD) announced today that Rex, the talking prescription bottle, is up for Best Embedded Solution at the 2004 Fourth Annual Speech Solutions Awards sponsored by Speech Technology Magazine. Speech Technology Magazine focuses on the development, application and integration of speech technology for business and consumer applications. The bi-monthly publication features in-depth articles on the emerging speech technology industry ranging from new product highlights to successful product deployments and insightful articles about the industry's leaders. Speech Technology Magazine is considered by many as the one of the most influential publications in the speech industry."Approximately 100,000 individuals die each year and billions of dollars are spent annually treating individuals who take medication improperly. Rex is a self-contained, disposable prescription bottle that uses text-to-speech technology (TTS) to read the medication information and instructions in a very natural computer generated voice," said Gene Franz, Products and Channels General Manager for Wizzard Software. "As the pharmacist prepares a prescription label, the same information is turned into audio and recorded onto the bottle. The user needs only to push a button on the bottle to hear the instructions. Rex is a wonderful assistive device for the blind, visually and cognitively impaired and other patients who have difficulty understanding how to properly take their medication. I believe Rex can make a huge contribution to saving lives and reducing health care cost." The awards will be handed out at SpeechTEK 2004, to be held at the Marriott Marquis in New York City, September 13th through the 16th. SpeechTEK is a world premier event dedicated exclusively to speech products, applications and solutions. Wizzard Software will again be participating in this event, the speech industry's number one trade show and educational forum. Wizzard will interact with a global network of vendors, enterprise executives and decision makers who are developing and implementing speech technology worldwide. In addition to participating in the conference, Wizzard will also be represented at several educational sessions to be conducted during the four-day event. SpeechTEK invited Gene Franz to moderate a SpeechTEK panel for the government sector and Tony Mariano, co-creator of Rex, to make a presentation in the health care sector. Finally, for the third year in a row, Chris Spencer, Wizzard's co-founder and CEO, is up for the award of `Top 10 Leaders in Speech'. This recognition is given to the ten most influential people in the speech technology industry over the previous year. To vote: http://www.speechtechmag.com/submissions/awards2004.html About Wizzard Software Founded in 1996, Wizzard Software has become a leader in the speech technology application development market. Wizzard architects solutions to business problems using its expertise in consulting, speech development tools and building speech based applications for the Desktop, Telephone and Internet. Wizzard has achieved global recognition because of its expertise with voice communication whether it is via PC or telephone. Wizzard's successes have lead to expanding opportunities in both the government and commercial sectors. In April of 2004, Wizzard acquired MedivoxRx Technologies. Founded in 2000, MedivoxRx is the originator of "Rex", the talking prescription pill bottle, which "talks" to the patient allowing them to distinguish what type of medication is in the bottle and hear critical information on dosage amounts and refill parameters. Additional information on MedivoxRx can be found at www.rxtalks.com. More information on Wizzard Software can be found in the Investor's Corner www.wizzardsoftware.com. Legal Notice Legal Notice Regarding Forward-Looking Statements: "Forward-looking Statements" as defined in the Private Securities litigation Reform Act of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. We disclaim any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions, actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, changes in our business strategies and acts of terror against the United States. |
